EP0423266A4 - Method and composition for treatment of periodontal disease - Google Patents

Method and composition for treatment of periodontal disease

Info

Publication number
EP0423266A4
EP0423266A4 EP19900905014 EP90905014A EP0423266A4 EP 0423266 A4 EP0423266 A4 EP 0423266A4 EP 19900905014 EP19900905014 EP 19900905014 EP 90905014 A EP90905014 A EP 90905014A EP 0423266 A4 EP0423266 A4 EP 0423266A4
Authority
EP
European Patent Office
Prior art keywords
composition
periodontal disease
chlorhexidine gluconate
allantoin
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900905014
Other versions
EP0423266A1 (en
Inventor
Marc N Benhuri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0423266A1 publication Critical patent/EP0423266A1/en
Publication of EP0423266A4 publication Critical patent/EP0423266A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles

Definitions

  • the present invention relates to a method and composition for treatment of periodontal disease and, more particularly, to a composition suitable for topical application to prevent and treat periodontitis.
  • Periodontal disease is the major cause of tooth loss in adults.
  • the periodontium is subject to inflammation for many reasons, primary among them being the accumulation of plaque deposits under and above the gumline.
  • These calcareous deposits of organic and mineral matter consist of microbial colonies growing in carbohydrate residues (from food) , attach themselves to tooth surfaces and can, over time, calcify into tartar. This hard, mineralized substance adheres tenaciously to the teeth and, when under the gumline, causes inflammation of the periodontium.
  • Other causes of periodontitis can include malocclusion, food impaction and mouth breathing.
  • Periodontitis outside of taking preventive measures to keep it from developing in the first place, was surgery.
  • the accepted surgical procedure involves removing the inflamed gum tissue, which is expensive and requires a long and painful recovery.
  • a composition suitable for treating periodontitis comprises an aqueous solution of an antimicrobial agent with bacteriacidal activity, an agent with therapeutic action against skin ulcers, an analgesic, a stain remover and, if desired, suitable wetting agents, emulsifiers, dispersants, buffers stabilizers, preservatives, flavoring and coloring.
  • the composition is used in a treatment method which comprises the steps of topically applying the composition to inflamed periodontium.
  • the various components of the composition of the present invention are present in an aqueous carrier of sterile distilled water, glycerine and ethanol.
  • the glycerine provides the composition with the desired feel and texture and the ethanol acts as an antiseptic.
  • chlorhexidine gluconate (0.12% solution), C 3 H 5 Cl 2 N 10 O 14 (Merck Index 2057) , as an antimicrobial agent with bacteriacidal action, (2) allantoin, or (2,5-dioxo-4- imidazolidinyl)urea (Merck Index 242) as an agent that exhibits therapeutic action against skin ulcers, (3) sodium salicylate, or 2-hydroxybenzoic acid monosodium salt (Merck Index 8515) , as an analgesic, and (4) sodium bicarbonate (Merck Index 8414) as a stain remover, along with wetting agents, preservatives, emulsifiers, dispersants, buffers stabilizers, flavoring and coloring, as desired. (All references herein to the Merck Index refer to the 1983 edition.)
  • the above ingredients are provided in the following proportions:
  • Ethanol (MI 212) 7.50% Polysorbate 80 (as an emulsifier and dispersant; MI 7455) 4.20% Chlorhexidine gluconate (0.12% sol.) (MI 2057) 3.50% Sodium bicarbonate (as a stain remover; MI 8414) 0.50% Sodium lauryl sulfate (as a wetting agent; MI 8474) 0.50%
  • MI 8413 0.10% Xanthan gum (as a stabilizer and e ulsifier; MI 9868) 0.10%
  • the above composition is prepared by first measuring an appropriate quantity of sterile distilled water; for example, lOOOcc of the composition is to be prepared, 101 . lc . of water are used. The remaining ingredients are added in the order listed in Table 1, with each ingredient being thoroughly mixed by gently stirring the composition before the next ingredient is added.
  • a clinical test involving 30 people was performed using a composition similar to that set out above, except for using 72.77% sterile water, 8.00% ethanol, 1.50% chlorhexidine gluconate (0.12% solution) and 0.138% allantoin.
  • the subjects were chosen because all exhibited, periodontal pockets up to 8mm or 9mm deep.
  • Prior to beginning the treatment regimen all 30 subjects agreed not to brush or floss their teeth for one week.
  • 15 of the subjects rinsed their mouths three times a day with 1.0 cc of the above composition 30 seconds before brushing and 15 rinsed their mouths three times a day with an equal amount of a colored sugar-water placebo 30 seconds before brushing.
  • the subjects did not know whether they were using the inventive composition or the placebo.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

A composition for treatment of periodontal disease includes an aqueous carrier of sterile water, glycerin and ethanol in which are present chlorhexidine gluconate, allantoin, sodium salicylate and sodium bicarbonate. A preferred method of treatment includes topical application to human periodontium in a mouthwash.

Description

METHOD AND COMPOSITION FOR TREATMENT OF PERIODONTAL DISEASE
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to a method and composition for treatment of periodontal disease and, more particularly, to a composition suitable for topical application to prevent and treat periodontitis.
Description of the Prior Art
Periodontal disease is the major cause of tooth loss in adults. The periodontium is subject to inflammation for many reasons, primary among them being the accumulation of plaque deposits under and above the gumline. These calcareous deposits of organic and mineral matter, which consist of microbial colonies growing in carbohydrate residues (from food) , attach themselves to tooth surfaces and can, over time, calcify into tartar. This hard, mineralized substance adheres tenaciously to the teeth and, when under the gumline, causes inflammation of the periodontium. Other causes of periodontitis can include malocclusion, food impaction and mouth breathing.
Periodontitis can cause the gumline to retract due to supporting bone loss and the gums to bleed, and eventually, if not treated, can result in tooth loss. Until now, the only known treatment for periodontitis, outside of taking preventive measures to keep it from developing in the first place, was surgery. The accepted surgical procedure involves removing the inflamed gum tissue, which is expensive and requires a long and painful recovery.
There have been various attempts at treating periodontal disease without such surgical intervention. The best such attempt to date resides in an oral rinse sold by Procter & Gamble under the name Peridex®. The chemistry of this product is described in the 1988 Phvsicans' Desk Reference at pages 1648-49. Unfortunately, Peridex® rinse has not proved as efficacious against periodontal disease as might be desired and exhibits unwanted side effects, such as staining of tooth surfaces.
The following patents also disclose oral treatment agents, but none is believed to represent a substitute for surgical intervention as a treatment for periodontal disease:
Re.31,397 4,213,961
2,684,924 4,332,791
3,887,712 4,339,430
3,925,543 4,454,110
3,937,807 4,486,404
3,957,967 4,569,837
4,051,234 4,601,900
4,067,962 4,661,342 4,198,392
Of interest with regard to the present invention are U.S. Patent 4,486,404 which, in Example 5, discloses a toothpaste containing chlorhexidine gluconate and allantoin, U.S. Patents 3,937,807 and 4,051,234, which disclose mouthwashes with gluconates and anti-stain agents, and U.S. Patent 4,569,837, which discloses the use of chlorhexidine gluconate and aspirin to treat periodontal disease. SUMMARY OF THE INVENTION It is an object of the present invention to provide a composition and method for treating Periodontitis I without costly and painful surgical intervention.
In accordance with one aspect of the invention, a composition suitable for treating periodontitis comprises an aqueous solution of an antimicrobial agent with bacteriacidal activity, an agent with therapeutic action against skin ulcers, an analgesic, a stain remover and, if desired, suitable wetting agents, emulsifiers, dispersants, buffers stabilizers, preservatives, flavoring and coloring.
In accordance with another aspect of the invention, the composition is used in a treatment method which comprises the steps of topically applying the composition to inflamed periodontium.
DESCRIPTION OF PREFERRED EMBODIMENTS In a preferred embodiment of the invention the various components of the composition of the present invention are present in an aqueous carrier of sterile distilled water, glycerine and ethanol. The glycerine provides the composition with the desired feel and texture and the ethanol acts as an antiseptic.
To this water-glycerine-ethanol carrier is added (1) chlorhexidine gluconate (0.12% solution), C3H5Cl2N10O14 (Merck Index 2057) , as an antimicrobial agent with bacteriacidal action, (2) allantoin, or (2,5-dioxo-4- imidazolidinyl)urea (Merck Index 242) as an agent that exhibits therapeutic action against skin ulcers, (3) sodium salicylate, or 2-hydroxybenzoic acid monosodium salt (Merck Index 8515) , as an analgesic, and (4) sodium bicarbonate (Merck Index 8414) as a stain remover, along with wetting agents, preservatives, emulsifiers, dispersants, buffers stabilizers, flavoring and coloring, as desired. (All references herein to the Merck Index refer to the 1983 edition.)
In particularly preferred embodiment, the above ingredients are provided in the following proportions:
TABLE 1
Sterile Water 70.77%
Glycerine (MI 4347) 11.15%
Ethanol (MI 212) 7.50% Polysorbate 80 (as an emulsifier and dispersant; MI 7455) 4.20% Chlorhexidine gluconate (0.12% sol.) (MI 2057) 3.50% Sodium bicarbonate (as a stain remover; MI 8414) 0.50% Sodium lauryl sulfate (as a wetting agent; MI 8474) 0.50%
Vanilla (as flavoring; MI 9732) 0.60%
Saccharine (as flavoring; MI 8170) 0.20%
Sodium salicylate (MI 8515) 0.15%
Allantoin (MI 242) 0.638% Sodium benzoate (as a preservative;
MI 8413) 0.10% Xanthan gum (as a stabilizer and e ulsifier; MI 9868) 0.10%
Sodium borate (as a buffer; MI 8421) 0.085%
F.D.& C. Blue (as coloring) 0.005%
F.D.& C. Red 40 (as coloring) 0.002%
[Notes to Table 1 - (1) All proportions of the above ingredients are v/v; (2) "MI" refers to the Merck Index]
The above composition is prepared by first measuring an appropriate quantity of sterile distilled water; for example, lOOOcc of the composition is to be prepared, 101 . lc . of water are used. The remaining ingredients are added in the order listed in Table 1, with each ingredient being thoroughly mixed by gently stirring the composition before the next ingredient is added.
A clinical test involving 30 people was performed using a composition similar to that set out above, except for using 72.77% sterile water, 8.00% ethanol, 1.50% chlorhexidine gluconate (0.12% solution) and 0.138% allantoin. The subjects were chosen because all exhibited, periodontal pockets up to 8mm or 9mm deep. Prior to beginning the treatment regimen, all 30 subjects agreed not to brush or floss their teeth for one week. Then, 15 of the subjects rinsed their mouths three times a day with 1.0 cc of the above composition 30 seconds before brushing and 15 rinsed their mouths three times a day with an equal amount of a colored sugar-water placebo 30 seconds before brushing. The subjects did not know whether they were using the inventive composition or the placebo.
Once a week the teeth of each subject were checked for the presence of plaque using a commercially available plaque- disclosing solution, Superdent® disclosing solution concentrate, made by Rugby Laboratories, Inc., of Rockville Centre, Long Island, NY 11570. All subjects using the inventive composition showed little or no plaque accumulation, while there was such plaque accumulation on the teeth of the subjects using the placebo.
The test procedures were continued for 12 weeks, and the subjects' conditions were measured in accordance with the Simplified Oral Hygiene Index (OHI-S) described in Orban's Periodontics (3rd Ed. 1968), The C.V. Mosby Co., St. Louis, MO, at page 134. It was found that the average OHI-S for the subjects on the placebo went from 8mm to 9mm periodontal pocket depth to 6mm to 8mm pocket depth during the 12 week test, while that for the subjects using the inventive composition improved from 8mm" to 9mm periodontal pocket depth to 2mm or 3mm pocket depth, which is considered within normal range.
It is expected that repeated use of the inventive solution will reduce inflammation, stop bleeding and keratenize damaged periodontal tissue.
Of course, variations of the above preferred embodiment are possible within the scope of the present invention, such as varying the proportions of the chlorhexidine gluconate, allantoin and sodium salicylate within ranges that provide efficacious results. It is intended by the claims appended below to include all such variations within the present invention.

Claims

WHAT I CLAIM IS :
1. A composition for treating periodontal disease comprising an aqueous carrier having therein chlorhexidine gluconate, allantoin and sodium salicylate.
2. A composition according to claim 1, further comprising a stain remover.
3. A composition according to claim 2, wherein said stain remover is sodium bicarbonate.
4. A composition according to claim 1, wherein said chlorhexidine gluconate is present as a 0.12% solution and said aqueous carrier consists essentially of sterile water, glycerine and ethanol.
5. A composition for treating periodontal disease consisting essentially of the following ingredients in the following amounts according to volume:
Sterile Water 70.77%
Glycerine 11.15%
Ethanol 7.50%
Polysorbate 80 4.20% Chlorhexidine gluconate (0.12% sol.) 3.50%
Sodium bicarbonate 0.50%
Sodium lauryl sulfate 0.50%
Sodium salicylate 0.15%
Allantoin 0.638% Xanthan gum 0.10%
Preservatives, buffers, flavoring and coloring 0.992%
6. A method for treating periodontal disease comprising the steps of: providing a composition including an aqueous carrier having therein chlorhexidine gluconate, allantoin and sodium salicylate; and applying said composition topically to a human periodontium.
7. A method according to claim 5, wherein the composition further includes a stain remover.
8. A method according to claim 6, wherein the stain remover is sodium bicarbonate.
EP19900905014 1989-02-28 1990-02-28 Method and composition for treatment of periodontal disease Withdrawn EP0423266A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31727189A 1989-02-28 1989-02-28
US317271 1989-02-28

Publications (2)

Publication Number Publication Date
EP0423266A1 EP0423266A1 (en) 1991-04-24
EP0423266A4 true EP0423266A4 (en) 1991-09-25

Family

ID=23232900

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900905014 Withdrawn EP0423266A4 (en) 1989-02-28 1990-02-28 Method and composition for treatment of periodontal disease

Country Status (4)

Country Link
EP (1) EP0423266A4 (en)
AU (1) AU5287090A (en)
CA (1) CA2028136A1 (en)
WO (1) WO1990009779A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257345B (en) 1992-06-02 1996-01-15 HIGHLY EFFECTIVE SCLEROSANT SOLUTION, WHICH DOES NOT PRODUCE IATROGEN INJURY AND PROCEDURE TO OBTAIN THIS SOLUTION.
US6486214B1 (en) 1997-09-10 2002-11-26 Rutgers, The State University Of New Jersey Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
US6468519B1 (en) 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US6531500B2 (en) 1999-07-23 2003-03-11 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US6673826B2 (en) 1999-07-23 2004-01-06 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US20020054895A1 (en) 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
US6896897B2 (en) 1999-07-23 2005-05-24 Alwyn Company, Inc. Flexible applicator for applying oil-in-water emulsion with improved stability
US6864274B2 (en) 1999-07-23 2005-03-08 Alwyn Company, Inc. Allantoin-containing skin cream
US6329413B1 (en) 1999-07-23 2001-12-11 Alwyn Company, Inc. Allantoin-containing skin cream
US6281236B1 (en) 1999-07-23 2001-08-28 Alwyn Company, Inc. Oil-in-water emulsion with improved stability
JP2003528044A (en) * 1999-12-07 2003-09-24 ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー Therapeutic compositions and methods of treatment
US6685928B2 (en) 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
CN103767886B (en) 2005-11-09 2018-04-24 科洛斯科技公司 Make the composition and method of dental whitening
WO2008034019A2 (en) 2006-09-13 2008-03-20 Polymerix Corporation Active agents and their oligomers and polymers
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
EA026962B1 (en) 2008-11-07 2017-06-30 Клокс Текнолоджиз Инк. Composition and method for treatment of acne rosacea
SI2453922T1 (en) * 2009-07-17 2018-04-30 Klox Technologies Inc. Antibacterial oral composition
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US9144579B2 (en) 2012-08-17 2015-09-29 Rutgers, The State University Of New Jersey Polyesters and methods of use thereof
KR20150082189A (en) 2012-09-14 2015-07-15 밸리언트 파마슈티컬즈 인터내셔널, 인코퍼레이션 Compositions and methods for teeth whitening
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair
WO2014194055A1 (en) 2013-05-29 2014-12-04 Rutgers, The State University Of New Jersey Antioxidant-based poly(anhydride-esters)
KR20210142011A (en) 2013-07-03 2021-11-23 광동 클록스 바이오메디컬 그룹 씨오., 엘티디 Biophotonic Compositions Comprising a Chromophore and a Gelling Agent for Treating Wounds
CN103893026B (en) * 2014-03-31 2018-04-06 陈光健 It is a kind of to be used for oral cleaning and the mouthwash of health care
MX2016012933A (en) 2014-04-01 2016-12-07 Klox Tech Inc Tissue filler compositions and methods of use.
US10023521B2 (en) 2014-06-13 2018-07-17 Rutgers, The State University Of New Jersey Process and intermediates for preparing poly(anhydride-esters)
RU2017117187A (en) 2014-10-31 2018-11-30 Клокс Текнолоджиз Инк. PHOTO-ACTIVATED FIBERS AND WOVEN MATERIALS
WO2016164898A1 (en) 2015-04-10 2016-10-13 Rutgers, The State University Of New Jersey Kojic acid polymers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2529271A1 (en) * 1975-07-01 1977-01-13 Erich Hofacker Treatment and prophylaxis of gum diseases - with compsn. contg. salt of chlorophenyl biguanide deriv. and pref. tetrahydroimidazole deriv.
EP0085891A1 (en) * 1982-01-26 1983-08-17 LABORATORI BALDACCI Spa A composition for the cleaning and hygien of teeth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370314A (en) * 1975-12-08 1983-01-25 Colgate-Palmolive Company Oral composition containing antibacterial agent
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
US4512968A (en) * 1982-11-30 1985-04-23 Lion Corporation Oral compositions
JPS59222406A (en) * 1983-06-01 1984-12-14 Teijin Ltd Pharmaceutical preparation for remedying periodontosis and its preparation
AU7204787A (en) * 1986-03-17 1987-10-09 Oral Research Laboratories, Inc. Treatment of dental surfaces with plaque retardants

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2529271A1 (en) * 1975-07-01 1977-01-13 Erich Hofacker Treatment and prophylaxis of gum diseases - with compsn. contg. salt of chlorophenyl biguanide deriv. and pref. tetrahydroimidazole deriv.
EP0085891A1 (en) * 1982-01-26 1983-08-17 LABORATORI BALDACCI Spa A composition for the cleaning and hygien of teeth

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9009779A1 *

Also Published As

Publication number Publication date
WO1990009779A1 (en) 1990-09-07
AU5287090A (en) 1990-09-26
CA2028136A1 (en) 1990-09-29
EP0423266A1 (en) 1991-04-24

Similar Documents

Publication Publication Date Title
EP0423266A4 (en) Method and composition for treatment of periodontal disease
Mandel Antimicrobial mouthrinses: overview and update
Ernst et al. The effectiveness and side effects of 0.1% and 0.2% chlorhexidine mouthrinses: a clinical study.
Rees et al. Oral ulcerations with use of hydrogen peroxide
US5236699A (en) Antiplaque mouth rinse
US4097604A (en) Method of treating and controlling gingivitis
JPS61501390A (en) dental rinse
US3651208A (en) Dentifrice for periodontia purposes
Mandel Calculus update: prevalence, pathogenicity and prevention
US5073363A (en) Foamable fluoride gels and method
US4215144A (en) Method of treating and controlling gingivitis
US4839158A (en) Process and composition for oral hygiene
US4214006A (en) Mouthwash and method for preventing and removing dental plaque
JP2981772B2 (en) Dental hygiene composition for reducing periodontal disease
US6589513B2 (en) Oral hygiene formulation and method of use
Holbeche et al. A clinical trial of the efficacy of a cetylpyridinium chloride‐based mouth wash*: 1. Effect on plaque accumulation and gingival condition
US5403579A (en) Process and composition for oral hygiene
US6497858B1 (en) Method of remineralizing teeth
JP2548265B2 (en) Oral hygiene medicine
US6440395B1 (en) Antiplaque mouth rinse
Kjaerheim et al. Experiments with triclosan-containing mouthrinses: dose response—and an attempt to locate the receptor site (s) of triclosan in the mouth
US20050180927A1 (en) Novel anti-bacterial compositions
US20070292371A1 (en) Composition for promoting and maintaining oral health
Yengopal Essential oils: some lesser known uses and properties for improved oral health
WO1987003476A1 (en) Composition for the treatment of periodontal disease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19901026

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19910808

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19920331